Extracellular Vesicles as Potential Therapeutics for Inflammatory Diseases

Int J Mol Sci. 2021 May 22;22(11):5487. doi: 10.3390/ijms22115487.

Abstract

Extracellular vesicles (EV) deliver cargoes such as nucleic acids, proteins, and lipids between cells and serve as an intercellular communicator. As it is revealed that most of the functions associated to EVs are closely related to the immune response, the important role of EVs in inflammatory diseases is emerging. EVs can be functionalized through EV surface engineering and endow targeting moiety that allows for the target specificity for therapeutic applications in inflammatory diseases. Moreover, engineered EVs are considered as promising nanoparticles to develop personalized therapeutic carriers. In this review, we highlight the role of EVs in various inflammatory diseases, the application of EV as anti-inflammatory therapeutics, and the current state of the art in EV engineering techniques.

Keywords: EV engineering; biomarker; extracellular vesicle; inflammatory disease.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Extracellular Vesicles / drug effects*
  • Extracellular Vesicles / metabolism*
  • Humans
  • Inflammation / drug therapy*
  • Inflammation / metabolism*
  • Nanoparticles / chemistry

Substances

  • Anti-Inflammatory Agents